1
|
Yang F, Peng L, Gao SQ. Full-length sequence of the novel allele, HLA-B*58:01:40, identified in a Chinese individual. HLA 2024; 103:e15378. [PMID: 38433661 DOI: 10.1111/tan.15378] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/11/2024] [Revised: 01/23/2024] [Accepted: 01/24/2024] [Indexed: 03/05/2024]
Abstract
HLA-B*58:01:40 differs from HLA-B*58:01:01 by a single nucleotide change in exon 3, 507 C- > T (codon 145.3 CGC- > CGT).
Collapse
Affiliation(s)
- Fan Yang
- Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| | - Long Peng
- Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| | - Su-Qing Gao
- Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, China
| |
Collapse
|
2
|
Agarwal S, Jaiswal N, Kumari S, Kumar V, Kumar R. Identification of the novel HLA-B*40:06:01:18 allele in a North Indian individual. HLA 2024; 103:e15436. [PMID: 38470352 DOI: 10.1111/tan.15436] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2024] [Revised: 02/26/2024] [Accepted: 02/28/2024] [Indexed: 03/13/2024]
Abstract
HLA-B*40:06:01:18 differs from HLA-B*40:06:01:02 by one nucleotide change in the 5'UTR (T > C).
Collapse
Affiliation(s)
- Samir Agarwal
- Department of Lab Science and Molecular Medicine, Army Hospital Research and Referral, New Delhi, India
| | - Nisha Jaiswal
- Department of Lab Science and Molecular Medicine, Army Hospital Research and Referral, New Delhi, India
| | - Shikha Kumari
- Department of Lab Science and Molecular Medicine, Army Hospital Research and Referral, New Delhi, India
| | - Vineeth Kumar
- Department of Lab Science and Molecular Medicine, Army Hospital Research and Referral, New Delhi, India
| | - Rajnesh Kumar
- Department of Lab Science and Molecular Medicine, Army Hospital Research and Referral, New Delhi, India
| |
Collapse
|
3
|
Stancil SL, Sandritter T, Strawn JR. Pharmacogenetics and Oxcarbazepine in Children and Adolescents: Beyond HLA-B*15:02. J Child Adolesc Psychopharmacol 2024; 34:61-66. [PMID: 38377523 PMCID: PMC10880270 DOI: 10.1089/cap.2023.0064] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/22/2024]
Abstract
Background: Oxcarbazepine is thought to be better-tolerated and less susceptible to drug-drug interactions than its predecessor, carbamazepine. Genetic testing for HLA-B*15:02 is recommended in specific populations to identify those at high risk of severe hypersensitivity reactions; however, other pharmacologic and pharmacogenetic factors that can impact drug disposition may be involved. Methods: We present a case of an 8-year-old boy treated with oxcarbazepine who developed drug reaction with eosinophilia and systemic symptoms (DRESS) with Stevens-Johnsons syndrome overlap and was negative for HLA-B*15:02. We review the extant literature related to oxcarbazepine disposition, and potential pharmacogenetic variants in aldoketoreductase 1C (AKR1C)2-4 that may contribute to this risk. Results: Genetic variability in oxcarbazepine disposition pathways may contribute to tolerability and toxicity, including the development of hypersensitivity reactions. Conclusions: While preemptive genetic testing for HLA-B*15:02 in individuals of Asian ancestry is recommended to prevent severe hypersensitivity reactions to oxcarbazepine, oxcarbazepine concentrations and AKR1C variation may contribute to the risk of severe adverse reactions. We provide recommendations for future study to elucidate whether these individual factors are important for reducing the risk of severe adverse events.
Collapse
Affiliation(s)
- Stephani L. Stancil
- Division of Adolescent Medicine, Children's Mercy Kansas City, Kansas City, Missouri, USA
- Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA
- Department of Pediatrics, University of Missouri–Kansas City School of Medicine, Kansas City, Missouri, USA
| | - Tracy Sandritter
- Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy Kansas City, Kansas City, Missouri, USA
| | - Jeffrey R. Strawn
- Department of Psychiatry and Behavioral Neuroscience and University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
- Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
| |
Collapse
|
4
|
Sharma A, Bagchi S, Barwad AW, Agarwal SK, Kanga U. One nucleotide substitution in the 3'UTR generated the novel allele HLA-B*40:01:02:47 in a North Indian individual. HLA 2024; 103:e15377. [PMID: 38342777 DOI: 10.1111/tan.15377] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2024] [Revised: 01/19/2024] [Accepted: 01/24/2024] [Indexed: 02/13/2024]
Abstract
HLA-B*40:01:02:47 differs from HLA-B*40:01:02:01 by one nucleotide change in the 3'UTR at position 2739 (A>T).
Collapse
Affiliation(s)
- Akanksha Sharma
- Department of Transplant Immunology and Immunogenetics, Clinical Immunogenetics Laboratory, Centre for Excellence in Molecular Medicine (ICMR), All India Institute of Medical Sciences, New Delhi, India
| | - Soumita Bagchi
- Department of Nephrology, All India Institute of Medical Sciences, New Delhi, India
| | - Adarsh W Barwad
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| | - Sanjay Kumar Agarwal
- Department of Nephrology, All India Institute of Medical Sciences, New Delhi, India
| | - Uma Kanga
- Department of Transplant Immunology and Immunogenetics, Clinical Immunogenetics Laboratory, Centre for Excellence in Molecular Medicine (ICMR), All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
5
|
Sharma A, Bagchi S, Barwad AW, Agarwal SK, Kanga U. Characterization of the novel HLA-B*15:05:01:02 allele by sequence-based typing. HLA 2024; 103:e15363. [PMID: 38305067 DOI: 10.1111/tan.15363] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/01/2024] [Revised: 01/11/2024] [Accepted: 01/16/2024] [Indexed: 02/03/2024]
Abstract
HLA-B*15:05:01:02 differs from HLA-B*15:05:01:01 by one nucleotide change in intron 2 at position 517 (C > A).
Collapse
Affiliation(s)
- Akanksha Sharma
- Department of Transplant Immunology and Immunogenetics, Clinical Immunogenetics Laboratory, Centre for Excellence in Molecular Medicine (ICMR), All India Institute of Medical Sciences, New Delhi, India
| | - Soumita Bagchi
- Department of Nephrology, All India Institute of Medical Sciences, New Delhi, India
| | - Adarsh W Barwad
- Department of Pathology, All India Institute of Medical Sciences, New Delhi, India
| | - Sanjay Kumar Agarwal
- Department of Nephrology, All India Institute of Medical Sciences, New Delhi, India
| | - Uma Kanga
- Department of Transplant Immunology and Immunogenetics, Clinical Immunogenetics Laboratory, Centre for Excellence in Molecular Medicine (ICMR), All India Institute of Medical Sciences, New Delhi, India
| |
Collapse
|
6
|
Ananeva A, Nizamov S, Andryushkina AV, Shagimardanova EI. Discovery of the novel HLA-B*39:198 allele, a variant of HLA-B*39:01:01, in a Russian individual. HLA 2024; 103:e15270. [PMID: 37877523 DOI: 10.1111/tan.15270] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Accepted: 10/09/2023] [Indexed: 10/26/2023]
Abstract
One nucleotide substitution in codon 336 of HLA-B*39:01:01:01 results in the novel allele, HLA- B*39:198.
Collapse
Affiliation(s)
- Anastasiia Ananeva
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Shamil Nizamov
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anna V Andryushkina
- National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation
| | - Elena I Shagimardanova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
- Loginov Moscow Clinical Scientific Center, Moscow, Russian Federation
| |
Collapse
|
7
|
Yang JJ, Oh HB. The HLA-B*58:01:43 allele identified in a Korean individual awaiting hematopoietic stem cell transplant. HLA 2024; 103:e15294. [PMID: 38093509 DOI: 10.1111/tan.15294] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2023] [Revised: 10/30/2023] [Accepted: 11/01/2023] [Indexed: 01/23/2024]
Abstract
HLA-B*58:01:43 differs from HLA-B*58:01:01:01 by one synonymous nucleotide substitution in codon 197.
Collapse
Affiliation(s)
- John Jeongseok Yang
- Department of Laboratory Medicine, Korea University College of Medicine, Seoul, Korea
| | - Heung-Bum Oh
- Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea
| |
Collapse
|
8
|
Alanazi H, Alshubaili A, Cereb N, Hajeer A, Jawdat D. Identification of the novel HLA-B*53:69 allele by sequencing-based typing. HLA 2024; 103:e15331. [PMID: 38174637 DOI: 10.1111/tan.15331] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/15/2023] [Revised: 11/29/2023] [Accepted: 12/04/2023] [Indexed: 01/05/2024]
Abstract
The HLA-B*53:69 allele differs from HLA-B*53:01:01:01 by two nucleotide changes in exon 3.
Collapse
Affiliation(s)
- Hanan Alanazi
- Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City-Riyadh, Ministry of National Guard Health Affairs / College of Medicine, King Saud bin Abdulaziz University for Health Sciences / King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
| | - Abdullah Alshubaili
- Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City-Riyadh, Ministry of National Guard Health Affairs / College of Medicine, King Saud bin Abdulaziz University for Health Sciences / King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
| | | | - Ali Hajeer
- Department of Pathology and Laboratory Medicine, King Abdulaziz Medical City-Riyadh, Ministry of National Guard Health Affairs / College of Medicine, King Saud bin Abdulaziz University for Health Sciences / King Abdullah International Medical Research Center, Riyadh, Saudi Arabia
| | - Dunia Jawdat
- Saudi Stem Cell Donor Registry, King Abdullah International Medical Research Center / College of Science and Health Professions, King Saud bin Abdulaziz University for Health Sciences / King Abdulaziz Medical City-Riyadh, Ministry of National Guard Health Affairs, Riyadh, Saudi Arabia
| |
Collapse
|
9
|
Ananeva A, Akhmetshina G, Andryushkina AV, Shagimardanova EI. The novel HLA-B*49:81 allele characterized by next-generation sequencing. HLA 2024; 103:e15275. [PMID: 37920125 DOI: 10.1111/tan.15275] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2023] [Revised: 10/11/2023] [Accepted: 10/14/2023] [Indexed: 11/04/2023]
Abstract
The novel HLA-B*49:81 allele differs by one nucleotide change from HLA-B*49:01:01.
Collapse
Affiliation(s)
- Anastasiia Ananeva
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia
| | - Gulnaz Akhmetshina
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia
| | - Anna V Andryushkina
- National Bone Marrow Donors Registry Named After Vasya Perevoshchikov, Moscow, Russia
| | - Elena I Shagimardanova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russia
- Loginov Moscow Clinical Scientific Center, Moscow, Russia
| |
Collapse
|
10
|
de Oliveira AML, Massi FP, Pinto LDB, Zacarias JMV, Visentainer JEL. Description of four new HLA-B alleles in Brazilian bone marrow donors. HLA 2024; 103:e15277. [PMID: 37916649 DOI: 10.1111/tan.15277] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2023] [Revised: 10/16/2023] [Accepted: 10/20/2023] [Indexed: 11/03/2023]
Abstract
Four new HLA-B alleles were identified in Brazilian individuals using next generation sequencing.
Collapse
Affiliation(s)
- Anthony Marçal Leão de Oliveira
- Department of Clinical Analysis and Biomedicine (DAB), Postgraduate Program in Biosciences and Physiopathology (PBF), Laboratory of Immunogenetics at the State University of Maringá (LIG-UEM), State University of Maringá (UEM), Maringá, Paraná, Brazil
| | - Fernanda Pelisson Massi
- Department of Clinical Analysis and Biomedicine (DAB), Postgraduate Program in Biosciences and Physiopathology (PBF), Laboratory of Immunogenetics at the State University of Maringá (LIG-UEM), State University of Maringá (UEM), Maringá, Paraná, Brazil
| | - Larissa Danielle Bahls Pinto
- Department of Basic Health Sciences (DBS), Laboratory of Immunogenetics at the State University of Maringá (LIG-UEM), State University of Maringá (UEM), Maringá, Paraná, Brazil
| | - Joana Maira Valentini Zacarias
- Department of Basic Health Sciences (DBS), Laboratory of Immunogenetics at the State University of Maringá (LIG-UEM), State University of Maringá (UEM), Maringá, Paraná, Brazil
| | - Jeane Eliete Laguila Visentainer
- Department of Basic Health Sciences (DBS), Laboratory of Immunogenetics at the State University of Maringá (LIG-UEM), State University of Maringá (UEM), Maringá, Paraná, Brazil
| |
Collapse
|
11
|
Du Z, Williams C, Santiago R, Ussery T, Elrefaei M. Identification of the novel HLA-B*57:168 allele by next generation sequencing. HLA 2024; 103:e15327. [PMID: 38073446 DOI: 10.1111/tan.15327] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Revised: 11/27/2023] [Accepted: 11/29/2023] [Indexed: 02/02/2024]
Abstract
HLA-B*57:168 differs from HLA-B*57:01:01:01 by one nucleotide substitution at codon 325 (TGC > TCC) in exon 7.
Collapse
Affiliation(s)
- Zeying Du
- Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA
| | - Charles Williams
- Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA
| | - Rodrigo Santiago
- Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA
| | - Totiana Ussery
- Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA
| | - Mohamed Elrefaei
- Clinical Histocompatibility Laboratory, Department of Laboratory and Pathology, Mayo Clinic, Jacksonville, Florida, USA
| |
Collapse
|
12
|
Nouar NH, Yafour N, Youcef BY, Bouhass R, Chekkal M, Brahimi M, Bekadja MA, Sahraoui T. HLA-B*58 and HLA-B*27 Play a Role in the Development of Acute Leukemia: A Case Control Study. Asian Pac J Cancer Prev 2024; 25:169-173. [PMID: 38285781 PMCID: PMC10911740 DOI: 10.31557/apjcp.2024.25.1.169] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/12/2023] [Accepted: 01/22/2024] [Indexed: 01/31/2024] Open
Abstract
BACKGROUND Acute leukemia (AL) constitutes a group of malignant hematological diseases with multifactor origins. Some human leukocyte alleles (HLA) may be important genetic risk factors for development of acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). It is still unknown whether there is a relationship between ALL and AML with some alleles of the major histocompatibility complex. Our study looks specifically at western and southwest Algerian populations. METHOD Using the polymerase chain reaction with the sequence specific probe (PCR- SSP) method, we investigated the relationship of HLA-B alleles in 163 Algerian AL patients and 293 controls from the same ethnic origin. The study ran from 2013 - 2020. RESULTS Allele frequencies of HLA-B*27 and HLA-B*58 was higher in AL patients compared with control individuals; p=0.05 and p=0.03 respectively. Interestingly, all patients carrying HLA-B*27 allele and 88% of patients carrying HLA-B*58 allele had AML. However, there were no significant differences when we compared these results with the rest of AL group (HLA-B*X allele) (p=0.387). Response to induction chemotherapy treatment were comparable between the two patient groups 67% and 65% (p=0.978) respectively. CONCLUSION These results suggest that the HLA-B*27 and HLA-B*58, may be factors predisposing individuals to acute leukemia, in west and southwest Algerian patients. A large-scale study is still needed to confirm these findings.
Collapse
Affiliation(s)
- Narimane Habour Nouar
- Laboratory of Developmental Biology and Differentiation, BP 1510 El M’Naouer, Oran 1 Ahmed Ben Bella University, 31000, Oran, Algeria.
| | - Nabil Yafour
- Hospital and University Establishment November 1, 1954, Department of Hematology and Cellular Therapy, BP 4166 Ibn Rochd, University of Oran 1, Ahmed Ben Bella, Faculty of Medicine, 31000 Oran, Algeria.
| | - Bouali Youcef Youcef
- Hospital and University Establishment November 1, 1954, Immunology Department, 31000 Oran, Algeria.
| | - Rachid Bouhass
- Hospital and University Establishment November 1, 1954, Department of Hematology and Cellular Therapy, BP 4166 Ibn Rochd, University of Oran 1, Ahmed Ben Bella, Faculty of Medicine, 31000 Oran, Algeria.
| | - Mohammed Chekkal
- Hospital and University Establishment November 1, 1954, Hemobiology Blood Transfusion Service, Blood Bank. Sincerely, 31000 Oran, Algeria.
| | - Mohamed Brahimi
- Hospital and University Establishment November 1, 1954, Department of Hematology and Cellular Therapy, BP 4166 Ibn Rochd, University of Oran 1, Ahmed Ben Bella, Faculty of Medicine, 31000 Oran, Algeria.
| | - Mohamed Amine Bekadja
- Hospital and University Establishment November 1, 1954, Department of Hematology and Cellular Therapy, BP 4166 Ibn Rochd, University of Oran 1, Ahmed Ben Bella, Faculty of Medicine, 31000 Oran, Algeria.
| | - Tewfik Sahraoui
- Laboratory of Developmental Biology and Differentiation, BP 1510 El M’Naouer, Oran 1 Ahmed Ben Bella University, 31000, Oran, Algeria.
| |
Collapse
|
13
|
Ananeva A, Osipova N, Elagina E, Andryushkina AV, Shagimardanova EI. Two novel HLA-B variants identified in Russian individuals, HLA-B*37:108 and -B*38:108. HLA 2024; 103:e15249. [PMID: 37816628 DOI: 10.1111/tan.15249] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Revised: 09/25/2023] [Accepted: 09/27/2023] [Indexed: 10/12/2023]
Abstract
HLA-B*37:108 and -B*38:108, two novel alleles detected in Russian individuals by next generation sequencing.
Collapse
Affiliation(s)
- Anastasiia Ananeva
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Nailia Osipova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Elmira Elagina
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anna V Andryushkina
- National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation
| | - Elena I Shagimardanova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
- Loginov Moscow Clinical Scientific Center, Moscow, Russian Federation
| |
Collapse
|
14
|
Bang HI, Choi S, Seo M, Park MY, Im HY. Identification of a novel HLA-B allele, HLA-B*54:47, in a Korean individual. HLA 2023; 102:758-760. [PMID: 37749977 DOI: 10.1111/tan.15230] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2023] [Revised: 09/11/2023] [Accepted: 09/13/2023] [Indexed: 09/27/2023]
Abstract
B*54:47 allele differs from B*54:01:01:01 in codon 74 in exon 2.
Collapse
Affiliation(s)
- Hae In Bang
- Department of Laboratory Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Korea
| | - Sooin Choi
- Department of Laboratory Medicine and Genetics, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
| | - Miyeon Seo
- Department of Laboratory Medicine, Soonchunhyang University Bucheon Hospital, Bucheon, Korea
| | - Moo-Yong Park
- Division of Nephrology, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea
| | | |
Collapse
|
15
|
Li D, Zeng Z, Zhao S, Ao X, Wu H, Zhang Z, Zhang S, Zhou X, Miao X. Human Leukocyte Antigen Polymorphism HLA-A*24:02 is Associated with Acute Liver Disease in HBV-Infected Han Chinese Adults. Immunol Invest 2023; 52:767-778. [PMID: 37417317 DOI: 10.1080/08820139.2023.2232409] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 07/08/2023]
Abstract
BACKGROUND Whether polymorphic Human Leukocyte Antigen (HLA)-A, HLA-B and HLA-DRB1 alleles were associated with acute liver disease after hepatitis B virus (HBV) infections was investigated. METHODS In this study, from initially 100 participants in each group, HLA-A, HLA-B and HLA-DRB1 sequences were available from 86 acute hepatitis B (AHB) patients and from 84 HBV-resistant individuals (controls), using sequencing-based typing allele groups and alleles that exhibited differences in distribution between the case and control groups were subjected to chi-squared and logistic regression analyses to identify those associated with AHB. A dose response analysis was also performed on the effect of HLA-A*24:02 allele number on acute liver disease following HBV infection. RESULTS The frequency distribution of HLA-B and HLA-DRB1 alleles in the control group were in Hardy-Weinberg Equilibrium (P > .05). HLA-A*24:02 (χ2 = 6.949, P = .008) occurred most frequently in the AHB and HLA-DRB1*12:02 (χ2 = 7.768, P = .005) in the control group. With adjustment for sex, the logistic regression model showed that the HLA-A*24:02 allele was significantly associated with AHB liver injury (P = .0326, OR = 2.270, 95% CI: 1.070-4.816), whereas the other HLA-A, HLA-B, and HLA-DRB1 alleles were not (P > .05). A linear response was observed for the association between HLA-A*24:02 allele number and acute liver disease after HBV infections (χ2 = 4.428, P = .025). CONCLUSION The HLA-A*24:02 allele may influence the severity of the cellular response to HBV infection, increasing the elimination of HBV-infected hepatocytes. The HLA-A*24:02 allele may be a potential screening marker for identifying people or regional populations in China at higher risk of acute liver disease following HBV infection.
Collapse
Affiliation(s)
- Dongliang Li
- Department of Hepatobiliary Disease, 900TH Hospital of Joint Logistics Support Force, Fuzhou General Clinical Medical College of Fujian Medical University, Fuzhou, China
| | - Zhiyu Zeng
- Department of Hepatobiliary Disease, 900TH Hospital of Joint Logistics Support Force, Fuzhou General Clinical Medical College of Fujian Medical University, Fuzhou, China
| | - Shumin Zhao
- Department of Infectious Disease, Chang Zheng Hospital, The Naval Military Medical University, Shanghai, China
| | - Xiulan Ao
- Department of Hepatobiliary Disease, 900TH Hospital of Joint Logistics Support Force, Fuzhou General Clinical Medical College of Fujian Medical University, Fuzhou, China
| | - Haicong Wu
- Department of Hepatobiliary Disease, 900TH Hospital of Joint Logistics Support Force, Fuzhou General Clinical Medical College of Fujian Medical University, Fuzhou, China
| | - Zhiqiang Zhang
- Department of Hepatobiliary Disease, 900TH Hospital of Joint Logistics Support Force, Fuzhou General Clinical Medical College of Fujian Medical University, Fuzhou, China
| | - Shian Zhang
- Department of Hepatobiliary Disease, 900TH Hospital of Joint Logistics Support Force, Fuzhou General Clinical Medical College of Fujian Medical University, Fuzhou, China
| | - Xiaolin Zhou
- Department of Hepatobiliary Disease, 900TH Hospital of Joint Logistics Support Force, Fuzhou General Clinical Medical College of Fujian Medical University, Fuzhou, China
| | - Xiaohui Miao
- Department of Infectious Disease, Chang Zheng Hospital, The Naval Military Medical University, Shanghai, China
| |
Collapse
|
16
|
Loginova M, Smirnova D, Paramonov I. Genomic sequence of the HLA-B*08:01:71, HLA-B*51:382, and HLA-B*55:01:30 alleles. HLA 2023; 102:621-622. [PMID: 37549885 DOI: 10.1111/tan.15184] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/25/2023] [Accepted: 07/26/2023] [Indexed: 08/09/2023]
Abstract
The full length sequence of the HLA-B*08:01:71, HLA-B*51:382 and HLA-B*55:01:30 alleles are reported.
Collapse
Affiliation(s)
- Maria Loginova
- Research Laboratory of Applied Immunogenetic, Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia
- Department of Microbiology, Federal State Budget Educational Institution of Higher Professional Education, Vyatka State University, Kirov, Russia
| | - Daria Smirnova
- Research Laboratory of Applied Immunogenetic, Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia
| | - Igor Paramonov
- Research Laboratory of Applied Immunogenetic, Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia
| |
Collapse
|
17
|
Zhong YP, Quan ZR, He LM, Zou HY. The novel HLA-B*13:179 variant detected by next generation sequencing in a Chinese individual. HLA 2023; 102:519-521. [PMID: 37431702 DOI: 10.1111/tan.15153] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/21/2023] [Revised: 06/26/2023] [Accepted: 06/28/2023] [Indexed: 07/12/2023]
Abstract
HLA-B*13:179 differs from HLA-B*13:99 by one nucleotide substitution at position 829(A>G) in exon 4.
Collapse
Affiliation(s)
- Yan-Ping Zhong
- Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China
| | - Zhan-Rou Quan
- Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China
| | - Liu-Mei He
- Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China
| | - Hong-Yan Zou
- Shenzhen Institute of Transfusion Medicine, Shenzhen Blood Center, Shenzhen, Guangdong, China
| |
Collapse
|
18
|
Shin S, Kim Y, Park H, Yoon JH, Roh EY. The novel HLA-B allele, HLA-B*15:656, first identified in a Korean individual by next-generation sequencing. HLA 2023. [PMID: 37226667 DOI: 10.1111/tan.15121] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/13/2023] [Revised: 05/15/2023] [Accepted: 05/17/2023] [Indexed: 05/26/2023]
Abstract
HLA-B*15:656 differs from B*15:27:01:01 by two nucleotide substitutions in codon 163 (CTG > GAG).
Collapse
Affiliation(s)
- Sue Shin
- Department of Laboratory Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea
- Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, South Korea
- Seoul Metropolitan Public Cord Blood Bank, Allcord, Seoul, South Korea
| | - Yumi Kim
- BioTIDE Co., Ltd., Seoul, South Korea
| | - Hyunwoong Park
- Department of Laboratory Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea
- Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, South Korea
| | - Jong Hyun Yoon
- Department of Laboratory Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea
- Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, South Korea
- Seoul Metropolitan Public Cord Blood Bank, Allcord, Seoul, South Korea
| | - Eun Youn Roh
- Department of Laboratory Medicine, Seoul National University Boramae Medical Center, Seoul, South Korea
- Department of Laboratory Medicine, Seoul National University College of Medicine, Seoul, South Korea
- Seoul Metropolitan Public Cord Blood Bank, Allcord, Seoul, South Korea
| |
Collapse
|
19
|
Jacques A, Dhuyser A, Kennel A, Clément S, Aarnink A. The novel HLA-B*14:118 allele characterized by two different sequencing-based typing techniques. HLA 2023. [PMID: 37157978 DOI: 10.1111/tan.15096] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2023] [Revised: 04/26/2023] [Accepted: 04/28/2023] [Indexed: 05/10/2023]
Abstract
HLA-B*14:118 differs from HLA-B*14:93 by two non-synonymous and one synonymous nucleotide substitution in exon 2.
Collapse
Affiliation(s)
- Alexandra Jacques
- HLA and histocompatibility laboratory, CHRU de Nancy, Vandoeuvre les Nancy, France
| | - Adèle Dhuyser
- HLA and histocompatibility laboratory, CHRU de Nancy, Vandoeuvre les Nancy, France
- IMoPa 6, UMR7365 CNRS, Université de Lorraine, Vandoeuvre-les-Nancy, France
| | - Anne Kennel
- HLA and histocompatibility laboratory, CHRU de Nancy, Vandoeuvre les Nancy, France
| | - Sandra Clément
- HLA and histocompatibility laboratory, CHRU de Nancy, Vandoeuvre les Nancy, France
| | - Alice Aarnink
- HLA and histocompatibility laboratory, CHRU de Nancy, Vandoeuvre les Nancy, France
- IMoPa 6, UMR7365 CNRS, Université de Lorraine, Vandoeuvre-les-Nancy, France
| |
Collapse
|
20
|
Shagimardanova EI, Aksenova L, Elvira Z, Ananeva A, Andryushkina AV. Characterization of the novel HLA-B*27:05:57 allele detected in a potential hematopoietic stem cell donor. HLA 2023. [PMID: 37158193 DOI: 10.1111/tan.15093] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/14/2023] [Revised: 04/24/2023] [Accepted: 04/25/2023] [Indexed: 05/10/2023]
Abstract
The novel HLA-B*27:05:57 allele differs by two nucleotide changes from HLA-B*27:05:02:01.
Collapse
Affiliation(s)
- Elena I Shagimardanova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Liliya Aksenova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Ziyatdinova Elvira
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anastasiia Ananeva
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anna V Andryushkina
- National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation
| |
Collapse
|
21
|
Youk HJ, Kwon OJ, Oh HB. Identification of the novel HLA-B*58:138 allele in a Korean individual. HLA 2023. [PMID: 37143388 DOI: 10.1111/tan.15055] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/23/2023] [Revised: 03/24/2023] [Accepted: 03/27/2023] [Indexed: 05/06/2023]
Abstract
HLA-B*58:138 differs from HLA-B*58:01:01:01 by one nucleotide substitution in exon 3 at codon 145.
Collapse
Affiliation(s)
- Hee-Jeong Youk
- Department of Laboratory Medicine, Kangwon National University Hospital, Kangwon National University School of Medicine, Chuncheon, Republic of Korea
| | - Oh-Joong Kwon
- Biowithus Life Science Institute, Seoul, Republic of Korea
| | - Heung-Bum Oh
- Department of Laboratory Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
22
|
Aksenova L, Ananeva A, Andryushkina AV, Shagimardanova EI. Identification of the novel HLA-B allele, B*51:01:101, by next-generation sequencing. HLA 2023. [PMID: 37128644 DOI: 10.1111/tan.15080] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Revised: 04/14/2023] [Accepted: 04/17/2023] [Indexed: 05/03/2023]
Abstract
The novel HLA-B*51:01:101 allele was characterized using next generation sequencing technology.
Collapse
Affiliation(s)
- Liliya Aksenova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anastasiia Ananeva
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anna V Andryushkina
- National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation
| | - Elena I Shagimardanova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| |
Collapse
|
23
|
Akhmetshina G, Ananeva A, Andryushkina AV, Shagimardanova EI. The novel HLA-B*08 allele, HLA-B*08:295, identified by next generation sequencing. HLA 2023. [PMID: 37127537 DOI: 10.1111/tan.15062] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/15/2023] [Revised: 03/30/2023] [Accepted: 04/03/2023] [Indexed: 05/03/2023]
Abstract
The novel HLA-B*08:295 allele was characterized using next generation sequencing technology.
Collapse
Affiliation(s)
- Gulnaz Akhmetshina
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anastasiia Ananeva
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anna V Andryushkina
- National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation
| | - Elena I Shagimardanova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| |
Collapse
|
24
|
Aksenova L, Ananeva A, Andryushkina AV, Shagimardanova EI. Discovery of the novel HLA-B*38:102 allele, a variant of HLA-B*38:01:01, in a Russian individual. HLA 2023. [PMID: 37105568 DOI: 10.1111/tan.15074] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/10/2023] [Accepted: 04/12/2023] [Indexed: 04/29/2023]
Abstract
One nucleotide substitution in codon 1 of HLA-B*38:01:01:01 results in the novel allele, HLA-B*38:102.
Collapse
Affiliation(s)
- Liliya Aksenova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anastasiia Ananeva
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anna V Andryushkina
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
- National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation
| | - Elena I Shagimardanova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| |
Collapse
|
25
|
Nizamov S, Ananeva A, Andryushkina AV, Shagimardanova EI. Identification and characterization of the novel HLA-B*39:189 allele by next-generation sequencing. HLA 2023. [PMID: 37088472 DOI: 10.1111/tan.15070] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/05/2023] [Revised: 04/07/2023] [Accepted: 04/08/2023] [Indexed: 04/25/2023]
Abstract
The novel HLA-B*39:189 allele was characterized using next generation sequencing technology.
Collapse
Affiliation(s)
- Shamil Nizamov
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anastasiia Ananeva
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anna V Andryushkina
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
- National Bone Marrow Donors Registry named after Vasya Perevoshchikov, Moscow, Russian Federation
| | - Elena I Shagimardanova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| |
Collapse
|
26
|
Silva NDSB, Souza ADS, Andrade HDS, Pereira RN, Castro CFB, Vince N, Limou S, Naslavsky MS, Zatz M, Duarte YADO, Mendes-Junior CT, Castelli EDC. Immunogenetics of HLA-B: SNP, allele, and haplotype diversity in populations from different continents and ancestry backgrounds. HLA 2023; 101:634-646. [PMID: 37005006 DOI: 10.1111/tan.15043] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2022] [Revised: 03/21/2023] [Accepted: 03/21/2023] [Indexed: 04/04/2023]
Abstract
HLA-B is among the most variable gene in the human genome. This gene encodes a key molecule for antigen presentation to CD8+ T lymphocytes and NK cell modulation. Despite the myriad of studies evaluating its coding region (with an emphasis on exons 2 and 3), few studies evaluated introns and regulatory sequences in real population samples. Thus, HLA-B variability is probably underestimated. We applied a bioinformatics pipeline tailored for HLA genes on 5347 samples from 80 different populations, which includes more than 1000 admixed Brazilians, to evaluate the HLA-B variability (SNPs, indels, MNPs, alleles, and haplotypes) in exons, introns, and regulatory regions. We observed 610 variable sites throughout HLA-B; the most frequent variants are shared worldwide. However, the haplotype distribution is geographically structured. We detected 920 full-length haplotypes (exons, introns, and untranslated regions) encoding 239 different protein sequences. HLA-B gene diversity is higher in admixed populations and Europeans while lower in African ancestry individuals. Each HLA-B allele group is associated with specific promoter sequences. This HLA-B variation resource may improve HLA imputation accuracy and disease-association studies and provide evolutionary insights regarding HLA-B genetic diversity in human populations.
Collapse
Affiliation(s)
- Nayane Dos Santos Brito Silva
- Molecular Genetics and Bioinformatics Laboratory, School of Medicine, São Paulo State University - Unesp, Botucatu, São Paulo, Brazil
- INSERM, Ecole Centrale Nantes, Center for Research in Transplantation and Translational Immunology, Nantes Université, UMR 1064, F-44000, Nantes, France
| | - Andreia da Silva Souza
- Molecular Genetics and Bioinformatics Laboratory, School of Medicine, São Paulo State University - Unesp, Botucatu, São Paulo, Brazil
| | - Heloisa de Souza Andrade
- Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), São Paulo, São Paulo, Brazil
| | - Raphaela Neto Pereira
- Molecular Genetics and Bioinformatics Laboratory, School of Medicine, São Paulo State University - Unesp, Botucatu, São Paulo, Brazil
| | - Camila Ferreira Bannwart Castro
- Molecular Genetics and Bioinformatics Laboratory, School of Medicine, São Paulo State University - Unesp, Botucatu, São Paulo, Brazil
- UniFSP, Centro Universitário Sudoeste Paulista, Itapetininga, São Paulo, Brazil
| | - Nicolas Vince
- INSERM, Ecole Centrale Nantes, Center for Research in Transplantation and Translational Immunology, Nantes Université, UMR 1064, F-44000, Nantes, France
| | - Sophie Limou
- INSERM, Ecole Centrale Nantes, Center for Research in Transplantation and Translational Immunology, Nantes Université, UMR 1064, F-44000, Nantes, France
| | - Michel Satya Naslavsky
- Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), São Paulo, São Paulo, Brazil
- Human Genome and Stem Cell Research Center, University of São Paulo, São Paulo, São Paulo, Brazil
- Hospital Israelita Albert Einstein, São Paulo, São Paulo, Brazil
| | - Mayana Zatz
- Department of Genetics and Evolutionary Biology, Biosciences Institute, University of São Paulo (USP), São Paulo, São Paulo, Brazil
- Human Genome and Stem Cell Research Center, University of São Paulo, São Paulo, São Paulo, Brazil
| | | | - Celso Teixeira Mendes-Junior
- Departamento de Química, Faculdade de Filosofia, Ciências e Letras de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brazil
| | - Erick da Cruz Castelli
- Molecular Genetics and Bioinformatics Laboratory, School of Medicine, São Paulo State University - Unesp, Botucatu, São Paulo, Brazil
| |
Collapse
|
27
|
Ananeva A, Vizerov T, Zabudskaya K, Gorelyshev A, Shagimardanova E. Identification of the novel HLA-B*07:458 allele, detected in two unrelated bone marrow donors. HLA 2023; 101:276-278. [PMID: 36416147 DOI: 10.1111/tan.14903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/01/2022] [Revised: 11/18/2022] [Accepted: 11/21/2022] [Indexed: 11/25/2022]
Abstract
HLA-B*07:458 has one non-synonymous nucleotide compared with HLA-B*07:02:01 in codon-21.
Collapse
Affiliation(s)
- Anastasiia Ananeva
- Institute of fundamental medicine and biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | | | | | | | - Elena Shagimardanova
- Institute of fundamental medicine and biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| |
Collapse
|
28
|
He Y, Chen N, Dong L, Zhang W, Zhu F. Characterization of the novel HLA-B*40:495 and HLA-B*40:512 alleles by next-generation sequencing. HLA 2023. [PMID: 36855232 DOI: 10.1111/tan.15012] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/22/2023] [Accepted: 02/24/2023] [Indexed: 03/02/2023]
Abstract
Compared with HLA-B*40:01:02:01, the alleles HLA-B*40:495 and HLA-B*40:512 each show one nucleotide substitution, respectively.
Collapse
Affiliation(s)
- Yizhen He
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| | - Nanying Chen
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| | - Lina Dong
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| | - Wei Zhang
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| | - Faming Zhu
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China
| |
Collapse
|
29
|
Bolaños J, Lorca-Arce D, Arnaldos-Perez C, Marti-Morente D, Serra-Pages C. Identification of a new HLA-B allele, HLA-B*51:371. HLA 2023; 101:170-171. [PMID: 36205591 DOI: 10.1111/tan.14844] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/05/2022] [Revised: 09/15/2022] [Accepted: 09/27/2022] [Indexed: 11/04/2022]
Abstract
A novel HLA-B*51 allele, officially designated HLA-B*51:371, was identified by next-generation sequencing.
Collapse
Affiliation(s)
| | | | | | | | - Carles Serra-Pages
- Immunology Service, Hospital Clinic Barcelona, Barcelona, Spain.,Department of Biomedicine, University of Barcelona, Barcelona, Spain.,Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
| |
Collapse
|
30
|
Ji Y, Zhao J, Ma H, Wu D, Zhu F. Characterization of the novel HLA-B*35:502 allele. HLA 2023; 101:673-674. [PMID: 36627743 DOI: 10.1111/tan.14971] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/25/2022] [Revised: 01/05/2023] [Accepted: 01/06/2023] [Indexed: 01/12/2023]
Abstract
The novel HLA-B*35:502 allele differs from HLA-B*35:01:01:01 at one position in exon 2.
Collapse
Affiliation(s)
- Yongping Ji
- Medical Test Laboratory, Blood Station of Lishui, Lishui, China
| | - Jing Zhao
- Medical Test Laboratory, Blood Station of Lishui, Lishui, China
| | - Haiyong Ma
- Medical Test Laboratory, Blood Station of Lishui, Lishui, China
| | - Dan Wu
- Medical Test Laboratory, Blood Station of Lishui, Lishui, China
| | - Faming Zhu
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.,HLA Typing Laboratory, Key Laboratory of Blood Safety Research, Hangzhou, China
| |
Collapse
|
31
|
Devriese M, Usureau C, Carmagnat M, Da Silva S, Taupin JL. Identification of a novel HLA-B allele, HLA-B*08:304. HLA 2023; 101:671-672. [PMID: 36594565 DOI: 10.1111/tan.14964] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/26/2022] [Revised: 12/29/2022] [Accepted: 12/30/2022] [Indexed: 01/04/2023]
Abstract
The novel allele B*08:304 differs from B*08:01:01:01 by one nucleotide substitution in exon 2.
Collapse
Affiliation(s)
- Magali Devriese
- Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.,INSERM UMR976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France
| | - Cedric Usureau
- Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.,INSERM UMR976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France
| | - Maryvonnick Carmagnat
- Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.,INSERM UMR976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France
| | - Sephora Da Silva
- Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.,INSERM UMR976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France
| | - Jean-Luc Taupin
- Laboratoire d'Immunologie et Histocompatibilité, Hôpital Saint Louis, Paris, France.,INSERM UMR976, Institut de Recherche Saint-Louis, Université de Paris, Paris, France
| |
Collapse
|
32
|
Ananeva A, Nizamov S, Shagimardanova E. Characterization of the novel HLA-B*35:547 allele detected in a potential hematopoietic stem cell donor. HLA 2023; 101:53-54. [PMID: 36175364 DOI: 10.1111/tan.14828] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/16/2022] [Accepted: 09/27/2022] [Indexed: 12/14/2022]
Abstract
The novel HLA-B*35:547 allele was characterized using next generation sequencing technology.
Collapse
Affiliation(s)
- Anastasiia Ananeva
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Shamil Nizamov
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Elena Shagimardanova
- Institute of Fundamental Medicine and Biology, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| |
Collapse
|
33
|
Park JS, Kim K. Antigen Coverage Presented by MHC Class I Has a Negative Correlation with SARS-CoV-2-Induced Mortality. Vaccines (Basel) 2022; 10:1917. [PMID: 36423013 PMCID: PMC9698063 DOI: 10.3390/vaccines10111917] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/21/2022] [Revised: 10/29/2022] [Accepted: 11/09/2022] [Indexed: 11/11/2023] Open
Abstract
The COVID-19 pandemic has caused a health crisis worldwide; therefore, it is necessary to understand the factors related to its prognosis. In this study, we hypothesized that SARS-CoV-2-derived antigens presented by MHC class I may correlate with mortality in COVID-19 because they induce adaptive immune responses. Antigen coverage at the national level was inferred using country-specific HLA allele frequencies and relative predictions of binding antigens. We performed regression analysis between antigen coverage and the death rate due to COVID-19 across countries and found a negative correlation, although it was statistically significant only in HLA-B. This negative correlation was corroborated in multiple regression analysis with known risk factors, such as the prevalence of underlying disease. Furthermore, we analyzed antigen coverage in accordance with SARS-CoV-2 domains and identified a significant negative correlation when it was derived from the spike domain, which is reported to be favorable for COVID-19 prognosis. Taken together, the results indicate that the antigen coverage of SARS-CoV-2 specifically presented by HLA-B may act as a favorable factor when explaining COVID-19-induced mortality.
Collapse
Affiliation(s)
- Ji Soo Park
- Department of Biology, Kyung Hee University, Seoul 02447, Korea
| | - Kwoneel Kim
- Department of Biology, Kyung Hee University, Seoul 02447, Korea
- Department of Biomedical and Pharmaceutical Sciences, Kyung Hee University, Seoul 02447, Korea
| |
Collapse
|
34
|
Hernandez PV, Duffy B, Hock K, Farnsworth C, Schindler E, Liu C. HLA-B evolutionary divergence is associated with outcomes after SARS-CoV-2 infection. Hum Immunol 2022:S0198-8859(22)00181-1. [PMID: 36109290 DOI: 10.1016/j.humimm.2022.09.004] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2022] [Revised: 07/28/2022] [Accepted: 09/06/2022] [Indexed: 12/04/2022]
Abstract
We examined the correlation between class I HLA evolutionary divergence (HED), a surrogate for the capacity to present different peptides, and the outcomes of 234 adult inpatients with confirmed SARS-CoV-2 infection. Genomic DNA was extracted from peripheral blood and genotyped by next-generation sequencing (NGS). HED scores for HLA class I (HLA-A, -B, and -C) genotypes were calculated using Grantham’s distance. Higher HED scores for HLA-B, but not HLA-A or -C, are significantly associated with a decreased probability of poor outcomes including ICU admission, mechanical ventilation, and death (OR = 0.93; P = 0.04) in the univariate analysis. In the multivariate analysis, increased HLA-B HED score, younger age, and no comorbidity were independently associated with favorable outcomes (P = 0.02, P = 0.01, and P = 0.05, respectively). This finding is consistent with the notion that broader peptide repertoires presented by class I HLA may be beneficial in infection control.
Collapse
|
35
|
Kitano Y, Nishimura S, Kato TM, Ueda A, Takigawa K, Umekage M, Nomura M, Kawakami A, Ogawa H, Xu H, Hotta A, Takasu N, Tsukahara M. Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application. Mol Ther Methods Clin Dev 2022; 26:15-25. [PMID: 35755947 PMCID: PMC9198376 DOI: 10.1016/j.omtm.2022.05.010] [Citation(s) in RCA: 14] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2021] [Accepted: 05/25/2022] [Indexed: 11/06/2022]
Abstract
In order to expand the promise of regenerative medicine using allogeneic induced pluripotent stem cells (iPSCs), precise and efficient genome editing of human leukocyte antigen (HLA) genes would be advantageous to minimize the immune rejection caused by mismatches of HLA type. However, clinical-grade genome editing of multiple HLA genes in human iPSC lines remains unexplored. Here, we optimized the protocol for good manufacturing practice (GMP)-compatible CRISPR-Cas9 genome editing to deplete the three gene locus (HLA-A, HLA-B, and CIITA genes) simultaneously in HLA homozygous iPSCs. The use of HLA homozygous iPSCs has one main advantage over heterozygous iPSCs for inducing biallelic knockout by a single gRNA. RNA-seq and flow cytometry analyses confirmed the successful depletion of HLAs, and lineage-specific differentiation into cardiomyocytes was verified. We also confirmed that the pluripotency of genome-edited iPSCs was successfully maintained by the three germ layers of differentiation. Moreover, whole-genome sequencing, karyotyping, and optical genome mapping analyses revealed no evident genomic abnormalities detected in some clones, whereas unexpected copy number losses, chromosomal translocations, and complex genomic rearrangements were observed in other clones. Our results indicate the importance of multidimensional analyses to ensure the safety and quality of the genome-edited cells. The manufacturing and assessment pipelines presented here will be the basis for clinical-grade genome editing of iPSCs.
Collapse
Affiliation(s)
- Yuko Kitano
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | - Sayaka Nishimura
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | - Tomoaki M Kato
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | - Anna Ueda
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | - Kaho Takigawa
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | - Masafumi Umekage
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | - Masaki Nomura
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | - Ayane Kawakami
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | - Haruna Ogawa
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | - Huaigeng Xu
- Center for iPS Cell Research and Application, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan.,Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, University of California, San Francisco, 35 Medical Center Way, San Francisco, CA 94143, USA
| | - Akitsu Hotta
- Center for iPS Cell Research and Application, Kyoto University, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8507, Japan
| | - Naoko Takasu
- CiRA Foundation, 53 Shogoin Kawahara-cho, Sakyo-ku, Kyoto 606-8397, Japan
| | | |
Collapse
|
36
|
Fernández-Torres J, Martínez-Nava GA, Martínez-Flores K, Sánchez-Sánchez R, Jara LJ, Zamudio-Cuevas Y. The interplay between HLA-B and NLRP3 polymorphisms may be associated with the genetic susceptibility of gout. Mol Biol Rep 2022; 49:10205-10215. [PMID: 36057006 DOI: 10.1007/s11033-022-07895-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2022] [Accepted: 08/22/2022] [Indexed: 11/24/2022]
Abstract
BACKGROUND HLA and NLRP3 play an important role in the development of various autoimmune and autoinflammatory diseases. Gout is an autoinflammatory disease associated with multiple genetic and environmental factors. The objective of the present study was to evaluate the interaction and association between genetic polymorphisms of HLA-B and the NLRP3 gene in Mexican patients with gout. METHODS AND RESULTS Eighty-one patients with gout were included and compared with 95 healthy subjects. The polymorphisms rs4349859, rs116488202, rs2734583 and rs3099844 (within the HLA-B region) and rs3806268 and rs10754558 of the NLRP3 gene were genotyped using TaqMan probes in a Rotor-Gene device. The interactions were determined using the multifactorial dimensionality reduction (MDR) method, while the associations were determined through logistic regression models. The MDR analysis revealed significant interactions between the rs116488202 and rs10754558 polymorphisms with an entropy value of 4.31% (p < 0.0001). Significant risk associations were observed with rs4349859 and rs116488202 polymorphisms (p < 0.01); however, no significant associations were observed with the polymorphisms of the NLRP3 gene. CONCLUSIONS The results suggest that HLA-B polymorphisms and their interaction with NLRP3 may contribute to the genetic susceptibility of gout.
Collapse
Affiliation(s)
- Javier Fernández-Torres
- Laboratorio de Líquido Sinovial, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico.,Biology Department, Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Mexico City, Mexico
| | | | - Karina Martínez-Flores
- Laboratorio de Líquido Sinovial, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico
| | - Roberto Sánchez-Sánchez
- Unidad de Ingeniería de Tejidos, Terapia Celular y Medicina Regenerativa, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico
| | - Luis J Jara
- Rheumatology Division, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico
| | - Yessica Zamudio-Cuevas
- Laboratorio de Líquido Sinovial, Instituto Nacional de Rehabilitación "Luis Guillermo Ibarra Ibarra", Mexico City, Mexico.
| |
Collapse
|
37
|
Dobrijević Z, Gligorijević N, Šunderić M, Penezić A, Miljuš G, Tomić S, Nedić O. The association of human leucocyte antigen (HLA) alleles with COVID-19 severity: A systematic review and meta-analysis. Rev Med Virol 2022; 33:e2378. [PMID: 35818892 PMCID: PMC9349710 DOI: 10.1002/rmv.2378] [Citation(s) in RCA: 8] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/01/2022] [Revised: 05/10/2022] [Accepted: 07/04/2022] [Indexed: 01/28/2023]
Abstract
Due to their pivotal role in orchestrating the immune response, HLA loci were recognized as candidates for genetic association studies related to the severity of COVID-19. Since the findings on the effects of HLA alleles on the outcome of SARS-CoV-2 infection remain inconclusive, we aimed to elucidate the potential involvement of genetic variability within HLA loci in the molecular genetics of COVID-19 by classifying the articles according to different disease severity/outcomes and by conducting a systematic review with meta-analysis. Potentially eligible studies were identified by searching PubMed, Scopus and Web of Science literature databases. A total of 28 studies with 13,073 participants were included in qualitative synthesis, while the results of 19 studies with 10,551 SARS-CoV-2-positive participants were pooled in the meta-analysis. According to the results of quantitative data synthesis, association with COVID-19 severity or with the lethal outcome was determined for the following alleles and allele families: HLA-A*01, HLA-A*03, HLA-A*11, HLA-A*23, HLA-A*31, HLA-A*68, HLA-A*68:02, HLA-B*07:02, HLA-B*14, HLA-B*15, HLA-B*40:02, HLA-B*51:01, HLA-B*53, HLA-B*54, HLA-B*54:01, HLA-C*04, HLA-C*04:01, HLA-C*06, HLA-C*07:02, HLA-DRB1*11, HLA-DRB1*15, HLA-DQB1*03 and HLA-DQB1*06 (assuming either allelic or dominant genetic model). We conclude that alleles of HLA-A, -B, -C, -DRB1 and -DQB1 loci may represent potential biomarkers of COVID-19 severity and/or mortality, which needs to be confirmed in a larger set of studies.
Collapse
Affiliation(s)
- Zorana Dobrijević
- Department for MetabolismUniversity of Belgrade—Institute for the Application of Nuclear EnergyBelgradeSerbia
| | - Nikola Gligorijević
- Department for MetabolismUniversity of Belgrade—Institute for the Application of Nuclear EnergyBelgradeSerbia
| | - Miloš Šunderić
- Department for MetabolismUniversity of Belgrade—Institute for the Application of Nuclear EnergyBelgradeSerbia
| | - Ana Penezić
- Department for MetabolismUniversity of Belgrade—Institute for the Application of Nuclear EnergyBelgradeSerbia
| | - Goran Miljuš
- Department for MetabolismUniversity of Belgrade—Institute for the Application of Nuclear EnergyBelgradeSerbia
| | - Sergej Tomić
- Department for Immunology and ImmunoparasitologyUniversity of Belgrade—Institute for the Application of Nuclear EnergyBelgradeSerbia
| | - Olgica Nedić
- Department for MetabolismUniversity of Belgrade—Institute for the Application of Nuclear EnergyBelgradeSerbia
| |
Collapse
|
38
|
Cai C, Yin Z, Liu A, Wang H, Zeng S, Wang Z, Qiu H, Li S, Zhou J, Wang M. Identifying Rare Genetic Variants of Immune Mediators as Risk Factors for Autism Spectrum Disorder. Genes (Basel) 2022; 13:1098. [PMID: 35741860 PMCID: PMC9223212 DOI: 10.3390/genes13061098] [Citation(s) in RCA: 5] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2022] [Revised: 06/16/2022] [Accepted: 06/17/2022] [Indexed: 12/30/2022] Open
Abstract
Autism spectrum disorder (ASD) affects more than 1% of children, and there is no viable pharmacotherapeutic agent to treat the core symptoms of ASD. Studies have shown that children with ASD show changes in their levels of immune response molecules. Our previous studies have shown that ASD is more common in children with folate receptor autoantibodies. We also found that children with ASD have abnormal gut immune function, which was characterized by a significant increase in the content of immunoglobulin A and an increase in gut-microbiota-associated epitope diversity. These studies suggest that the immune mechanism plays an important role in the occurrence of ASD. The present study aims to systematically assess gene mutations in immune mediators in patients with ASD. We collected genetic samples from 72 children with ASD (2−12 years old) and 107 healthy controls without ASD (20−78 years old). We used our previously-designed immune gene panel, which can capture cytokine and receptor genes, the coding regions of MHC genes, and genes of innate immunity. Target region sequencing (500×) and bioinformatics analytical methods were used to identify variants in immune response genes associated with patients with ASD. A total of 4 rare variants were found to be associated with ASD, including HLA-B: p.A93G, HLA-DQB1: p.S229N, LILRB2: p.R322H, and LILRB2: c.956-4C>T. These variants were present in 44.44% (32/72) of the ASD patients and were detected in 3.74% (4/107) of the healthy controls. We expect these genetic variants will serve as new targets for the clinical genetic assessment of ASD, and our findings suggest that immune abnormalities in children with ASD may have a genetic basis.
Collapse
Affiliation(s)
- Chunquan Cai
- Tianjin Pediatric Research Institute, Tianjin Key Laboratory of Birth Defects for Prevention and Treatment, Tianjin Children’s Hospital (Children’s Hospital of Tianjin University), No. 238 Longyan Road, Beichen District, Tianjin 300134, China;
| | - Zhaoqing Yin
- Division of Neonatology, The People’s Hospital of Dehong Autonomous Prefecture, Mangshi 678400, China;
| | - Aiping Liu
- The Department of Laboratory, Public Health Service Center of Bao’an District, Bao’an District, Shenzhen 518018, China;
| | - Hui Wang
- Xiamen Branch of Children’s Hospital of Fudan University (Xiamen Children’s Hospital), Xiamen 361006, China;
| | - Shujuan Zeng
- Division of Neonatology, Longgang Central Hospital of Shenzhen, Shenzhen 518116, China; (S.Z.); (H.Q.)
| | - Zhangxing Wang
- Division of Neonatology, Shenzhen Longhua People’s Hospital, Shenzhen 518109, China;
| | - Huixian Qiu
- Division of Neonatology, Longgang Central Hospital of Shenzhen, Shenzhen 518116, China; (S.Z.); (H.Q.)
| | - Shijun Li
- Department of Radiology, Chinese People’s Liberation Army General Hospital, Beijing 100853, China
| | - Jiaxiu Zhou
- Division of Psychology, Shenzhen Children’s Hospital, Shenzhen 518038, China
| | - Mingbang Wang
- Microbiome Therapy Center, South China Hospital of Shenzhen University, Shenzhen 518111, China
- Shanghai Key Laboratory of Birth Defects, Division of Neonatology, Children’s Hospital of Fudan University, Shanghai 201102, China
| |
Collapse
|
39
|
Koomdee N, Kloypan C, Jinda P, Rachanakul J, Jantararoungtong T, Sukprasong R, Prommas S, Nuntharadthanaphong N, Puangpetch A, Ershadian M, John S, Biswas M, Sukasem C. Evolution of HLA-B Pharmacogenomics and the Importance of PGx Data Integration in Health Care System: A 10 Years Retrospective Study in Thailand. Front Pharmacol 2022; 13:866903. [PMID: 35450046 PMCID: PMC9016335 DOI: 10.3389/fphar.2022.866903] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/31/2022] [Accepted: 03/17/2022] [Indexed: 11/13/2022] Open
Abstract
Background: The HLA-B is the most polymorphic gene, play a crucial role in drug-induced hypersensitivity reactions. There is a lot of evidence associating several risk alleles to life-threatening adverse drug reactions, and a few of them have been approved as valid biomarkers for predicting life-threatening hypersensitivity reactions. Objectives: The objective of this present study is to present the progression of HLA-B pharmacogenomics (PGx) testing in the Thai population during a 10‐year period, from 2011 to 2020. Methods: This was a retrospective observational cohort study conducted at the Faculty of Medicine Ramathibodi Hospital. Overall, 13,985 eligible patients who were tested for HLA-B risk alleles between periods of 2011–2020 at the study site were included in this study. Results: The HLA PGx testing has been increasing year by year tremendously, 94 HLA-B testing was done in 2011; this has been raised to 2,880 in 2020. Carbamazepine (n = 4,069, 33%), allopurinol (n = 4,675, 38%), and abacavir (n = 3,246, 26%) were the most common drugs for which the HLA-B genotyping was performed. HLA-B*13:01, HLA-B*15:02 and HLA-B*58:01 are highly frequent, HLA-B*51:01 and HLA-B*57:01 are moderately frequent alleles that are being associated with drug induced hypersensitivity. HLA-B*59:01 and HLA-B*38:01 theses alleles are rare but has been reported with drug induced toxicity. Most of the samples were from state hospital (50%), 36% from private clinical laboratories and 14% from private hospitals. Conclusion: According to this study, HLA-B PGx testing is increasing substantially in Thailand year after year. The advancement of research in this field, increased physician awareness of PGx, and government and insurance scheme reimbursement assistance could all be factors. Incorporating PGx data, along with other clinical and non-clinical data, into clinical decision support systems (CDS) and national formularies, on the other hand, would assist prescribers in prioritizing therapy for their patients. This will also aid in the prediction and prevention of serious adverse drug reactions.
Collapse
Affiliation(s)
- Napatrupron Koomdee
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Chiraphat Kloypan
- Unit of Excellence in Integrative Molecular Biomedicine, School of Allied Health Sciences, University of Phayao, Phayao, Thailand.,Division of Clinical Immunology and Transfusion Science, Department of Medical Technology, School of Allied Health Sciences, University of Phayao, Phayao, Thailand
| | - Pimonpan Jinda
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Jiratha Rachanakul
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Thawinee Jantararoungtong
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Rattanaporn Sukprasong
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Santirhat Prommas
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Nutthan Nuntharadthanaphong
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Apichaya Puangpetch
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Maliheh Ershadian
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Shobana John
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand
| | - Mohitosh Biswas
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.,Department of Pharmacy, University of Rajshahi, Rajshahi, Bangladesh
| | - Chonlaphat Sukasem
- Division of Pharmacogenomics and Personalized Medicine, Department of Pathology, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.,Laboratory for Pharmacogenomics, Somdech Phra Debaratana Medical Center (SDMC), Ramathibodi Hospital, Bangkok, Thailand.,Pharmacogenomics and Precision Medicine, The Preventive Genomics and Family Check-up Services Center, Bumrungrad International Hospital, Bangkok, Thailand.,MRC Centre for Drug Safety Science, Department of Pharmacology and Therapeutics, Molecular and Integrative Biology, Institute of Systems, University of Liverpool, Liverpool, United Kingdom
| |
Collapse
|
40
|
Liu L, Han B, Jiao S, Pang S. Genomic full-length sequence of the HLA-B*52:100 allele, identified by full-length group-specific sequencing. HLA 2022; 100:167-169. [PMID: 35411691 DOI: 10.1111/tan.14631] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/24/2022] [Revised: 04/06/2022] [Accepted: 04/08/2022] [Indexed: 11/27/2022]
Abstract
Genomic full-length sequence of HLA-B*52:100 was identified by group-specific sequencing in a Chinese individual. This article is protected by copyright. All rights reserved.
Collapse
Affiliation(s)
- Li Liu
- HLA Typing Lab, Institute of Transfusion Medicine, Qingdao Blood Center, Qingdao, Shandong Province 266071, China
| | - Bin Han
- HLA Typing Lab, Institute of Transfusion Medicine, Qingdao Blood Center, Qingdao, Shandong Province 266071, China
| | - Shuxian Jiao
- HLA Typing Lab, Institute of Transfusion Medicine, Qingdao Blood Center, Qingdao, Shandong Province 266071, China
| | - Shutao Pang
- HLA Typing Lab, Institute of Transfusion Medicine, Qingdao Blood Center, Qingdao, Shandong Province 266071, China
| |
Collapse
|
41
|
Loginova M, Smirnova D, Kutyavina S, Paramonov I. The HLA-B*58:01:42 allele identified in a volunteer bone marrow donor. HLA 2021; 99:391-392. [PMID: 34889079 DOI: 10.1111/tan.14510] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/02/2021] [Revised: 12/06/2021] [Accepted: 12/07/2021] [Indexed: 11/30/2022]
Abstract
HLA-B*58:01:42 differs from HLA-B*58:01:01:01 in codon 303 in exon 5.
Collapse
Affiliation(s)
- Maria Loginova
- Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia
| | - Daria Smirnova
- Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia
| | - Svetlana Kutyavina
- Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia
| | - Igor Paramonov
- Federal State Budget Research Institution, Kirov Hematology and Blood Transfusion Research Institute under the Federal Medicine and Biology Agency, Kirov, Russia
| |
Collapse
|
42
|
Neeraja M, Iyyapu R, Kumar NR, Manoj G, Tatapudi RR. Identification of the novel allele, HLA-B*44:256, in an individual from West Bengal in Eastern India. HLA 2021; 99:46-48. [PMID: 34628728 DOI: 10.1111/tan.14451] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/30/2021] [Revised: 10/05/2021] [Accepted: 10/06/2021] [Indexed: 11/29/2022]
Abstract
Next generation sequencing based HLA typing has led to the identification of a novel allele HLA-B*44:256. The novel allele HLA-B*44:256 differs from B*44:02:01:01 by eight nucleotides in exon 3.
Collapse
Affiliation(s)
- Mamidi Neeraja
- Department of Transplant Immunology, Apollo Hospitals, Jubilee Hills, Hyderabad, India
| | - Rohit Iyyapu
- Department of Transplant Immunology, Apollo Hospitals, Jubilee Hills, Hyderabad, India
| | - Neerudi Raj Kumar
- Department of Transplant Immunology, Apollo Hospitals, Jubilee Hills, Hyderabad, India
| | - Gorle Manoj
- Department of Transplant Immunology, Apollo Hospitals, Jubilee Hills, Hyderabad, India
| | | |
Collapse
|
43
|
Feng Z, Jiao S, Hu B, Pang S. Genomic full-length sequence of the HLA-B*52:23 allele was identified by full length group-specific sequencing. HLA 2021; 99:48-50. [PMID: 34601827 DOI: 10.1111/tan.14435] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2021] [Revised: 09/29/2021] [Accepted: 09/30/2021] [Indexed: 11/26/2022]
Abstract
Genomic full-length sequence of HLA-B*52:23 was identified by a group-specific sequencing approach in a Chinese individual.
Collapse
Affiliation(s)
- Zhihui Feng
- HLA Typing Laboratory, Qingdao Blood Center, Qingdao, China
| | - Shuxian Jiao
- HLA Typing Laboratory, Qingdao Blood Center, Qingdao, China
| | - Bin Hu
- HLA Typing Laboratory, Qingdao Blood Center, Qingdao, China
| | - Shutao Pang
- HLA Typing Laboratory, Qingdao Blood Center, Qingdao, China
| |
Collapse
|
44
|
Gonçalves LB, de França PP, Petry NA, de Souza Xavier MB, de Carvalho NS, Bicalho MDG, Boldt ABW, de Araujo-Souza PS. Inside the pocket: Critical elements of HLA-mediated susceptibility to cervical precancerous lesions. HLA 2021; 98:448-458. [PMID: 34505756 DOI: 10.1111/tan.14429] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/10/2020] [Revised: 09/02/2021] [Accepted: 09/06/2021] [Indexed: 01/10/2023]
Abstract
Human papillomavirus (HPV) infection is a necessary cause for cervical cancer (CC), but it also depends on genetic factors, such as HLA polymorphism. However, few reports addressed the role of amino acids residues at the HLA peptide-binding cleft in HPV-related cervical disease. Therefore, we aimed to investigate the association between HLA-B, HLA-C, and HLA-DRB1 polymorphism and amino acid residues composing the pockets of the peptide-binding cleft of the respective polypeptide chains with cervical intraepithelial neoplasia (CIN II/III). HLA typing was performed by PCR-SSOP in 184 women with CIN II/III and 174 controls from South Brazil. Associations were estimated by multivariate logistic regression. FDR test was performed to correct the p-value for multiple comparisons. HLA-DRB1*13:01 was associated with protection against CIN II/III, while HLA-C*03:04 was associated with susceptibility. The amino acid residues isoleucine, tyrosine, and leucine at positions 95, 116, and 163 of HLA-C, respectively, were associated with CIN II/III susceptibility. In contrast, serine at positions 11 and 13 of HLA-DRB1 was associated with protection against the disease. Our results confirm previously reported associations between HLA and cervical diseases caused by HPV and suggest a role for amino acid residues at different positions of HLA-C and HLA-DRB1 in CIN II/III. This finding may be further explored to better understand the genetic risk and the influence of immune response to CC development.
Collapse
Affiliation(s)
- Letícia Boslooper Gonçalves
- Laboratory of Immunogenetics and Histocompatibility, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil.,Post-graduation Program in Genetics, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil
| | - Patrícia Pinho de França
- Laboratory of Immunogenetics and Histocompatibility, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil.,Post-graduation Program in Genetics, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil
| | - Natália Angelica Petry
- Laboratory of Immunogenetics and Histocompatibility, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil
| | - Marina Bárbara de Souza Xavier
- Laboratory of Immunogenetics and Histocompatibility, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil.,Post-graduation Program in Genetics, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil
| | - Newton Sérgio de Carvalho
- Department of Gynecology and Obstetrics, Post Graduate Program of Gynecology and Obstetrics, Hospital de Clínicas, Universidade Federal do Paraná (UFPR), Curitiba, Brazil
| | - Maria da Graça Bicalho
- Laboratory of Immunogenetics and Histocompatibility, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil
| | - Angelica Beate Winter Boldt
- Laboratory of Human Molecular Genetics, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil
| | - Patrícia Savio de Araujo-Souza
- Laboratory of Immunogenetics and Histocompatibility, Department of Genetics, Universidade Federal do Paraná (UFPR), Curitiba, Brazil
| |
Collapse
|
45
|
Alghamdi M, Aldosari MA, Alkhaibari A, Matyuri AS, Hajeer AH. Characterization of the novel HLA-B*57:02:01:03 allele by sequencing-based typing. HLA 2021; 98:555-556. [PMID: 34418323 DOI: 10.1111/tan.14415] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/11/2021] [Revised: 08/15/2021] [Accepted: 08/16/2021] [Indexed: 01/02/2023]
Abstract
Two-nucleotide changes in the 3' UTR of HLA-B*57:02:01:01 result in the novel HLA-B*57:02:01:03 allele.
Collapse
Affiliation(s)
- Mohammed Alghamdi
- HLA Typing Lab, Department of Pathology and Laboratory Medicine, KSAU-HS, MNGHA, Riyadh, Saudi Arabia
| | - Manar A Aldosari
- HLA Typing Lab, Department of Pathology and Laboratory Medicine, KSAU-HS, MNGHA, Riyadh, Saudi Arabia
| | - Abdulrhman Alkhaibari
- HLA Typing Lab, Department of Pathology and Laboratory Medicine, KSAU-HS, MNGHA, Riyadh, Saudi Arabia
| | - Abdullah S Matyuri
- HLA Typing Lab, Department of Pathology and Laboratory Medicine, KSAU-HS, MNGHA, Riyadh, Saudi Arabia
| | - Ali H Hajeer
- HLA Typing Lab, Department of Pathology and Laboratory Medicine, KSAU-HS, MNGHA, Riyadh, Saudi Arabia
| |
Collapse
|
46
|
Birtsas V, Batrinou A, Dinou A, Routsias J, Gennimata V, Iniotaki A, Spyropoulou M, Tsakris A. Distribution of MICA alleles and haplotypes associated with HLA-B in Greek population. Hum Immunol 2021; 82:588-592. [PMID: 33966912 DOI: 10.1016/j.humimm.2021.04.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/23/2020] [Revised: 04/15/2021] [Accepted: 04/23/2021] [Indexed: 11/27/2022]
Abstract
INTRODUCTION The Major Histocompatibility Complex Class I-related chain A gene (MICA) is a highly polymorphic functional gene located close to the HLA-B locus. Certain MICA alleles have been related to inflammatory and autoimmune diseases while MICA antibodies have been implicated in organ allograft rejection or graft-versus-host disease (GVHD). AIM The aim of this study was to identify the frequencies of MICA alleles and MICA ~ HLA-B haplotypes in the Greek population since, as far as we know, these data are still limited. METHODS DNA was obtained from 277 unrelated healthy Greek individuals of Caucasian origin, volunteer donors of blood stem cells. HLA-B* and MICA* genotyping was performed by reverse PCR-SSOP. RESULTS A total of 18 MICA alleles were defined in the present study. The five most frequent alleles in the Greek population were MICA*008 (24.6%), MICA*009 (22.36%), MICA*018 (16.03%), MICA*002 (8.02%) and MICA*004 (7.17%) which altogether account for 77.8% of all alleles. The most common MICA ~ HLA-B haplotypes were MICA*018 ~ B*18 (12.5%) and MICA*009 ~ B*51(11.5%). CONCLUSIONS The five most frequent MICA alleles in the Greek population were *008, *009, *018, *002, *004. In other Caucasian populations, two of these alleles (*008, and *004) were observed in similar frequencies. MICA*002 was observed less frequently (8.02%) in the Greek population compared to other Caucasian groups (frequencies > 15%). Also, MICA*009 and MICA*018 had elevated frequencies (above 15%) whereas in other Caucasian populations they were found around 10% or less. These data may be important for the elucidation of the role that MICA polymorphisms play in organ and stem cell transplantation and to identify the relation of certain MICA with susceptibility to specific diseases.
Collapse
Affiliation(s)
- Vassilios Birtsas
- Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece; National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", Athens, Greece.
| | - Anthimia Batrinou
- Department of Biomedical Sciences and Department of Food Science and Technology, University of West Attica, Athens, Greece
| | - Amalia Dinou
- National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", Athens, Greece
| | - John Routsias
- Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - Vassiliki Gennimata
- Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| | - Aliki Iniotaki
- National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", Athens, Greece
| | - Maria Spyropoulou
- National Tissue Typing Center, General Hospital of Athens "G. Gennimatas", Athens, Greece
| | - Athanassios Tsakris
- Department of Microbiology, Medical School, National and Kapodistrian University of Athens, Athens, Greece
| |
Collapse
|
47
|
Shreeve N, Depierreux D, Hawkes D, Traherne JA, Sovio U, Huhn O, Jayaraman J, Horowitz A, Ghadially H, Perry JRB, Moffett A, Sled JG, Sharkey AM, Colucci F. The CD94/NKG2A inhibitory receptor educates uterine NK cells to optimize pregnancy outcomes in humans and mice. Immunity 2021; 54:1231-1244.e4. [PMID: 33887202 PMCID: PMC8211638 DOI: 10.1016/j.immuni.2021.03.021] [Citation(s) in RCA: 32] [Impact Index Per Article: 10.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Revised: 12/13/2020] [Accepted: 03/25/2021] [Indexed: 12/13/2022]
Abstract
The conserved CD94/NKG2A inhibitory receptor is expressed by nearly all human and ∼50% of mouse uterine natural killer (uNK) cells. Binding human HLA-E and mouse Qa-1, NKG2A drives NK cell education, a process of unknown physiological importance influenced by HLA-B alleles. Here, we show that NKG2A genetic ablation in dams mated with wild-type males caused suboptimal maternal vascular responses in pregnancy, accompanied by perturbed placental gene expression, reduced fetal weight, greater rates of smaller fetuses with asymmetric growth, and abnormal brain development. These are features of the human syndrome pre-eclampsia. In a genome-wide association study of 7,219 pre-eclampsia cases, we found a 7% greater relative risk associated with the maternal HLA-B allele that does not favor NKG2A education. These results show that the maternal HLA-B→HLA-E→NKG2A pathway contributes to healthy pregnancy and may have repercussions on offspring health, thus establishing the physiological relevance for NK cell education. Video Abstract
CD94/NKG2A educates uterine NK cells NKG2A-deficient dams display reduced utero-placental hemodynamic adaptations Asymmetric growth restriction and abnormal brain development in NKG2A-deficient dams Non-functional HLA-B→HLA-E→NKG2A pathway exposes women to greater pre-eclampsia risk
Collapse
Affiliation(s)
- Norman Shreeve
- Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK
| | - Delphine Depierreux
- Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK
| | - Delia Hawkes
- Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK
| | | | - Ulla Sovio
- Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK
| | - Oisin Huhn
- Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge, UK; AstraZeneca, Granta Park, Cambridge CB21 6GH, UK
| | - Jyothi Jayaraman
- University of Cambridge Centre for Trophoblast Research, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge, UK; Department of Physiology, Development and Neurobiology, University of Cambridge, Cambridge, UK
| | - Amir Horowitz
- Department of Oncological Sciences, Precision Immunology Institute and Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | | | - John R B Perry
- MRC Epidemiology Unit, University of Cambridge, Cambridge UK
| | - Ashley Moffett
- University of Cambridge Centre for Trophoblast Research, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge, UK
| | - John G Sled
- Department of Medical Biophysics, University of Toronto, Toronto, Canada; Translational Medicine, Hospital for Sick Children, Toronto, Canada
| | - Andrew M Sharkey
- University of Cambridge Centre for Trophoblast Research, Cambridge, UK; Department of Pathology, University of Cambridge, Cambridge, UK
| | - Francesco Colucci
- Department of Obstetrics & Gynaecology, University of Cambridge, National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge CB2 0SW, UK; University of Cambridge Centre for Trophoblast Research, Cambridge, UK.
| |
Collapse
|
48
|
Leite MDM, Gonzalez-Galarza FF, Silva BCCD, Middleton D, Santos EJMD. Predictive immunogenetic markers in COVID-19. Hum Immunol 2021; 82:247-254. [PMID: 33546902 PMCID: PMC7817393 DOI: 10.1016/j.humimm.2021.01.008] [Citation(s) in RCA: 20] [Impact Index Per Article: 6.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Revised: 11/22/2020] [Accepted: 01/04/2021] [Indexed: 02/05/2023]
Abstract
Immunorelevant genes are among the most probable modulators of coronavirus disease 2019 (COVID-19) progression and prognosis. However, in the few months of the pandemic, data generated on host genetics has been scarce. The present study retrieved data sets of HLA-B alleles, KIR genes and functional single nucleotide polymorphisms (SNPs) in cytokines related to COVID-19 cytokine storm from two publicly available databases: Allele Frequency Net Database and Ensembl, and correlated these frequency data with Case Fatality Rate (CFR) and Daily Death Rates (DDR) across countries. Correlations of eight HLA-B alleles and polymorphisms in three cytokine genes (IL6, IL10, and IL12B) were observed and were mainly associated with DDR. Additionally, HLA-B correlations suggest that differences in allele affinities to SARS-CoV-2 peptides are also associated with DDR. These results may provide rationale for future host genetic marker surveys on COVID-19.
Collapse
Affiliation(s)
- Mauro de Meira Leite
- Genetics of Complex Diseases Laboratory, Federal University of Pará, Belém, Brazil; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Belém, Brazil.
| | - Faviel F Gonzalez-Galarza
- Institute of Integrative Biology, University of Liverpool, Liverpool, UK; Center for Biomedical Research, Faculty of Medicine, Autonomous University of Coahuila, Torreon, Mexico
| | - Bruno Conde Costa da Silva
- Genetics of Complex Diseases Laboratory, Federal University of Pará, Belém, Brazil; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Belém, Brazil
| | - Derek Middleton
- Institute of Integrative Biology, University of Liverpool, Liverpool, UK
| | - Eduardo José Melo Dos Santos
- Genetics of Complex Diseases Laboratory, Federal University of Pará, Belém, Brazil; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Belém, Brazil
| |
Collapse
|
49
|
Leonov E, Khamaganova E, Abdrakhimova A, Khizhinskiy S, Savchenko V. HLA-A*24:521 and HLA-B*13:152 identified by next-generation sequencing in Russian bone marrow donors. HLA 2021; 97:531-532. [PMID: 33709549 DOI: 10.1111/tan.14252] [Citation(s) in RCA: 3] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/04/2021] [Accepted: 03/05/2021] [Indexed: 11/27/2022]
Abstract
Two novel alleles, HLA-A*24:521 and HLA-B*13:152, are characterized.
Collapse
Affiliation(s)
- Evgeny Leonov
- Laboratory for Tissue Typing, National Research Center for Hematology, Moscow, Russia
| | - Ekaterina Khamaganova
- Laboratory for Tissue Typing, National Research Center for Hematology, Moscow, Russia
| | - Alena Abdrakhimova
- Laboratory for Tissue Typing, National Research Center for Hematology, Moscow, Russia
| | - Stanislav Khizhinskiy
- Laboratory for Tissue Typing, National Research Center for Hematology, Moscow, Russia
| | - Valeriy Savchenko
- Laboratory for Tissue Typing, National Research Center for Hematology, Moscow, Russia
| |
Collapse
|
50
|
Fakhoury H, Alburaq M, AlSebaiheen F, Alshubaili A, Hajeer AH. Identification of a novel HLA-B*18 variant, HLA-B*18:01:01:52, in a Saudi individual. HLA 2021; 97:359-360. [PMID: 33301641 DOI: 10.1111/tan.14161] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/29/2020] [Revised: 12/03/2020] [Accepted: 12/04/2020] [Indexed: 12/01/2022]
Abstract
A single nucleotide change in the 3' UTR of HLA-B*18:01:01:01 results in the novel HLA-B*18:01:01:52 allele.
Collapse
Affiliation(s)
- Hana Fakhoury
- Department of Biochemistry and Molecular Biology, College of Medicine, Alfaisal University, Riyadh, Saudi Arabia
| | - Mohammed Alburaq
- HLA Typing Lab, Department of Pathology and Laboratory Medicine, KSAU-HS, MNGHA, Riyadh, Saudi Arabia
| | - Farrah AlSebaiheen
- HLA Typing Lab, Department of Pathology and Laboratory Medicine, KSAU-HS, MNGHA, Riyadh, Saudi Arabia
| | - Abdullah Alshubaili
- HLA Typing Lab, Department of Pathology and Laboratory Medicine, KSAU-HS, MNGHA, Riyadh, Saudi Arabia
| | - Ali H Hajeer
- HLA Typing Lab, Department of Pathology and Laboratory Medicine, KSAU-HS, MNGHA, Riyadh, Saudi Arabia
| |
Collapse
|